As genomics-focused pharmacology begins to play a greater role in cancer treatment, next-generation sequencing (NGS) is emerging as a valuable method for obtaining a deeper and more accurate look into the molecular underpinnings of individual tumors. With targeted therapies becoming the new standard of care in oncology, NGS-driven companion diagnostics are widely seen as driving the selection of treatments to optimize patient outcomes in the future.
Initiatives such as the Understand Your Genome (UYG) symposium aim to educate patients and providers on the future promise of personalized medicine. This event brings the professional and practitioner community together to discuss the clinical potential of NGS, with the hope that these conversations will inform how society pursues the journey to individualized health care.
NGS has the potential to change the future of oncology and advance the promise of personalized medicine. We invite you to learn more by examining the resources collected here.